August 12, 2020

Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months (Subscription Required)

July 08, 2020

Eikonizo Therapeutics Announces Publication of the First-in-Human Study of [18F]EKZ-001 and Expansion of Leadership Team, Adding Extensive Experience in Preclinical and Clinical Development

June 25, 2020

Episode 59: Using Tau to Target Alzheimer’s

June 2, 2020

UNDER THE MICROSCOPE: LUDO VAN DEN BOSCH ON RETURNING TO WORK, EXPLORING THERAPEUTIC STRATEGIES TO BATTLE ALS & FTD

May 5, 2020

TARGET ALS AND AFTD ANNOUNCE $5MM IN GRANTS FOR RESEARCH TARGETING TREATMENTS AND BIOMARKERS

April 1, 2020

Making Progress On A Micro-Budget

March 20, 2020

Eikonizo: brain-penetrant HDAC inhibitors for neurodegeneration (Subscription Required)

March 10, 2020

Women of the C-Suite: “Your career path might not always be linear,” With Janice Kranz, PhD of Eikonizo Therapeutics

March 4, 2020

Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer's And Other Dementia

2019

December 30, 2019

Mass. Biotech Sector Feels Drug Pricing Pressure

December 9, 2019

Untangling tau protein (Subscription Required)

October 23, 2019

New Approaches to Alzheimer’s and Tauopathies: Eikonizo Therapeutics

September 24, 2019

Dementia-Treatment Startup Seeks to Overcome Prior Drugs’ Failures

(Subscription Required)